To estimate cumulative lung cancer diagnosis rates among participants in community-based lung cancer screening (LCS) and incidental pulmonary nodule (IPN) programs in the Mississippi Delta, a region with high lung cancer incidence.
Key Findings:
Lung cancer screening via LDCT reduced lung cancer mortality by 20% and all-cause mortality by 8%, highlighting the effectiveness of early detection.
The study population included a diverse demographic, addressing the underrepresentation of Black participants in previous trials, which is crucial for equitable healthcare.
Incidental pulmonary nodule programs identified patients at risk not typically eligible for LCS, suggesting a need for broader screening criteria.
Interpretation:
The findings suggest that community-based LCS and IPN programs can effectively identify lung cancer in diverse populations, potentially improving early detection and treatment outcomes.
Limitations:
The study may not fully capture the lung cancer risk in all demographic groups due to the exclusion of certain populations, potentially skewing results.
Data collection relied on electronic health records, which may have inherent inaccuracies, affecting the reliability of findings.
Conclusion:
Community-based lung cancer screening initiatives in the Mississippi Delta show promise in improving early detection rates and addressing health disparities in lung cancer outcomes, warranting further research and policy support.
